Documentos de Trémollieres F.A. | REDI

Regresar

Mostrando 9 resultados de: 9

Filtros aplicados

Área temáticas: "Enfermedades"

Subtipo de publicación

Publisher

Área temáticas

Ginecología, obstetricia, pediatría, geriatría(7)

Farmacología y terapéutica(3)

Salud y seguridad personal(2)

Medicina y salud(1)

Problemas sociales y servicios a grupos(1)

Área de conocimiento

Ginecología(5)

Medicina interna(2)

Estudios de género(1)

Año de Publicación

Origen

Palabras Claves

Bisphosphonates(2)

Breast Cancer(2)

Aromatase inhibitors(1)

Bisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al.

Palabras claves:

Anagnostis P., Ceausu I., Depypere H., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Mueck A., Paschou S.A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A.

EMAS clinical guide: Assessment of the endometrium in peri and postmenopausal women

Abstract: Introduction Invasive as well as non-invasive methods are available for assessment of the endometriu

Palabras claves:

Clinical guide, Curettage, Endometrial assessment, Endometrial biopsy, Endometrial bleeding, Ultrasound

Antonsen S.L., Ceausu I., Depypere H., Dreisler E., Erel T., Faustino R. Pérez-López, Lambrinoudaki I., Poulsen L.G., Rees M., Simoncini T., Trémollieres F.A., Ulrich L.G.

EMAS clinical guide: Low-dose vaginal estrogens for postmenopausal vaginal atrophy

Abstract: Vaginal atrophy is common in postmenopausal women. This clinical guide provides the evidence for the

Palabras claves:

Low-dose, Postmenopausal, Vaginal atrophy, Vaginal estrogens

Ceasu I., Depypere H., Erel T., Faustino R. Pérez-López, Lambrinoudaki I., Rees M., Schenck-Gustafsson K., Simoncini T., Trémollieres F.A., van der Schouw Y.T.

EMAS clinical guide: Vulvar lichen sclerosus in peri and postmenopausal women

Abstract: Introduction: Vulvar lichen sclerosus (LS) is a chronic inflammatory disease which affects genital l

Palabras claves:

Calcineurin inhibitors, Clobetasol propionate, Corticosteroids, dyspareunia, Lichen sclerosus, Pimecrolimus, pruritus, Tacrolimus, Testosterone, Vulvar kraurosis

Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Rees M., Schenck-Gustafsson K., Simoncini T., Tamer Erel C., Trémollieres F.A., van der Schouw Y.T.

EMAS position statement: Individualized breast cancer screening versus population-based mammography screening programmes

Abstract: Introduction Breast cancer is the most prevalent cancer in women, with slightly more than ten percen

Palabras claves:

Breast Cancer, Individualized, Mammography screening

Ceausu I., Depypere H., Desreux J., Erel T., Faustino R. Pérez-López, Lambrinoudaki I., Rees M., Schenck-Gustafsson K., Simoncini T., Trémollieres F.A., van der Schouw Y.T.

EMAS position statement: Management of uterine fibroids

Abstract: Introduction Uterine fibroids (also termed leiomyomas or myomas) are the most common tumors of the f

Palabras claves:

Fibroids, Gn-RH analogs, High-intensity focused ultrasound, hysterectomy, Myomectomy, Ulipristal, Uterine artery embolization

Ceausu I., Depypere H., Erel T., Faustino R. Pérez-López, Lambrinoudaki I., Ornat L., Rees M., Schenck-Gustafsson K., Simoncini T., Trémollieres F.A.

Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement

Abstract: Background Bisphosphonates and denosumab are used extensively in the treatment of postmenopausal ost

Palabras claves:

Alendronate, Bisphosphonates, Denosumab, Drug holiday, Risedronate, Zoledronic acid

Anagnostis P., Ceausu I., Depypere H., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Mueck A., Paschou S.A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A.

Non-hormonal management of menopausal vasomotor symptoms: Psychosocial interventions

Palabras claves:

Ceausu I., Depypere H., Erel T., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Rees M., Schenck-Gustafsson K., Simoncini T., Trémollieres F.A.

Osteoporosis management in patients with breast cancer: EMAS position statement

Abstract: Aromatase inhibitors (AIs) are the first-line recommended standard of care for postmenopausal estrog

Palabras claves:

adjuvant therapy, Aromatase inhibitors, Bisphosphonates, Breast Cancer, Denosumab, fractures, OSTEOPOROSIS, screening

Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A., van der Schouw Y.T.